
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 5.570 | 5.570 | 0.000 |
Shares | 94.510 | 94.510 | 0.000 |
Bonds | 0.170 | 0.170 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.423 | 26.300 |
Price to Book | 2.191 | 3.288 |
Price to Sales | 1.959 | 4.479 |
Price to Cash Flow | 15.736 | 20.099 |
Dividend Yield | 2.948 | 2.136 |
5 Years Earnings Growth | 8.408 | 8.150 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 98.870 | 96.666 |
Consumer Cyclical | 1.100 | 0.679 |
Industrials | 0.010 | 0.528 |
Technology | 0.010 | 0.481 |
Number of long holdings: 143
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
APT Medical | CNE100004C45 | 1.18 | 325.81 | -1.82% | |
WuXi AppTec | CNE1000031K4 | 1.18 | 100.79 | -0.11% | |
Sinocelltech Group | CNE100003ZL3 | 1.14 | 51.14 | -3.02% | |
Jiangsu Hengrui | CNE0000014W7 | 1.13 | 64.72 | -0.83% | |
Qingdao Baheal Medical | CNE100004LR8 | 1.10 | 25.69 | -1.12% | |
Xiamen Amoytop Biotech Co | CNE100003RT3 | 1.10 | 73.00 | -5.58% | |
Pacific Shuanglin Bio pharmacy | CNE000000F14 | 1.10 | 16.31 | +0.31% | |
Pharmaron Beijing | CNE100003JW4 | 1.10 | 30.97 | +0.03% | |
iRay Technology | CNE1000042V8 | 1.09 | 113.87 | +0.41% | |
Hangzhou Tigermed Consulting | CNE100001KV8 | 1.08 | 52.09 | -2.12% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
TianHong SH Exchange 300 Index Fd A | 8.92B | 19.28 | 9.01 | 5.90 | ||
TianHong ChiNext Index A | 8.06B | 49.79 | 12.58 | 4.70 | ||
TianHong ChiNext Index C | 8.06B | 49.57 | 12.36 | 4.46 | ||
TianHong CSI Bank A | 4.89B | 4.90 | 13.79 | 6.70 | ||
TianHong CSI Bank C | 4.89B | 4.75 | 13.56 | 6.47 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review